Report Questions Pfizer's Anti-Smoking Drug

Law360, New York (October 22, 2008, 12:00 AM EDT) -- Nonprofit researchers called for increased scrutiny of Pfizer Inc.’s Chantix following reports that the smoking-cessation drug had caused more serious injuries than any other drug in the first quarter.

The Institute for Safe Medication Practices released a study on Wednesday that claims that varenicline, a drug Pfizer markets under the names Chantix and Champix, reported more than 1,000 health problems and injuries, including 50 deaths, in the first quarter of 2008.

It is the second consecutive quarter that Chantix has had the most serious injuries, according...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.